BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22008086)

  • 1. The connective tissue changes of Crohn's disease.
    Shelley-Fraser G; Borley NR; Warren BF; Shepherd NA
    Histopathology; 2012 Jun; 60(7):1034-44. PubMed ID: 22008086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice.
    Sheehan AL; Warren BF; Gear MW; Shepherd NA
    Br J Surg; 1992 Sep; 79(9):955-8. PubMed ID: 1422768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link.
    Borley NR; Mortensen NJ; Jewell DP; Warren BF
    J Pathol; 2000 Feb; 190(2):196-202. PubMed ID: 10657019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased gelsolin expression and retarded collagen lattice contraction with smooth muscle cells from Crohn's diseased intestine.
    Ehrlich HP; Allison GM; Page MJ; Kolton WA; Graham M
    J Cell Physiol; 2000 Feb; 182(2):303-9. PubMed ID: 10623895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mural bridging lesions in colonic Crohn's disease.
    Poller DN; Armitage NC
    Arch Pathol Lab Med; 1993 May; 117(5):550-2. PubMed ID: 8489349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
    Zulian A; Cancello R; Micheletto G; Gentilini D; Gilardini L; Danelli P; Invitti C
    Gut; 2012 Jan; 61(1):86-94. PubMed ID: 21930728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, visceral fat and Crohn's disease.
    Bertin B; Desreumaux P; Dubuquoy L
    Curr Opin Clin Nutr Metab Care; 2010 Sep; 13(5):574-80. PubMed ID: 20625283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease.
    Mao R; Doyon G; Gordon IO; Li J; Lin S; Wang J; Le THN; Elias M; Kurada S; Southern B; Olman M; Chen M; Zhao S; Dejanovic D; Chandra J; Mukherjee PK; West G; Van Wagoner DR; Fiocchi C; Rieder F
    Gut; 2022 Jan; 71(1):55-67. PubMed ID: 33468536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of granulomas to blood vessels in intestinal Crohn's disease.
    Matson AP; Van Kruiningen HJ; West AB; Cartun RW; Colombel JF; Cortot A
    Mod Pathol; 1995 Aug; 8(6):680-5. PubMed ID: 8532706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.
    Chen W; Lu C; Hirota C; Iacucci M; Ghosh S; Gui X
    J Crohns Colitis; 2017 Jan; 11(1):92-104. PubMed ID: 27364949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS; Burnett DA; Markin RS; Vaughan WP
    Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creeping Fat in the Pathogenesis of Crohn's Disease: An Orchestrator or a Silent Bystander?
    Tsounis EP; Aggeletopoulou I; Mouzaki A; Triantos C
    Inflamm Bowel Dis; 2023 Nov; 29(11):1826-1836. PubMed ID: 37260352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Mao R; Kurada S; Gordon IO; Baker ME; Gandhi N; McDonald C; Coffey JC; Rieder F
    Inflamm Bowel Dis; 2019 Feb; 25(3):421-426. PubMed ID: 30346528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue inflammation: presenting feature of Crohn's disease in a cystic fibrosis adolescent.
    Panagopoulou P; Fotoulaki M; Tsitouridis I; Nousia-Arvanitakis S
    J Cyst Fibros; 2007 Sep; 6(5):366-8. PubMed ID: 17341449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological and immunohistochemical features to distinguish between adipocyte hyperplasia, atrophy and neoplasia: differential diagnosis of small round adipocytes in Crohn's disease.
    Chui MH; Streutker CJ; Mulligan AM; Iakovlev VV
    Histopathology; 2012 Nov; 61(5):984-5. PubMed ID: 22803967
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of fat and adipokines in intestinal inflammation.
    Kredel L; Batra A; Siegmund B
    Curr Opin Gastroenterol; 2014 Nov; 30(6):559-65. PubMed ID: 25188546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD.
    Westcott ED; Mattacks CA; Windsor AC; Knight SC; Pond CM
    Ann N Y Acad Sci; 2006 Aug; 1072():395-400. PubMed ID: 17057221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical inflammatory myopathy associated with Crohn's disease.
    Heuss D; Hauser I; Riess R
    Clin Neuropathol; 1996; 15(3):150-4. PubMed ID: 8793249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
    Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
    Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.